There are 108 resources available
610O - Final overall survival (OS) analysis of PROfound: Olaparib vs physician’s choice of enzalutamide or abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations
Presenter: Johann de Bono
Session: Presidential Symposium II
Resources:
Abstract
Slides
Webcast
LBA5_PR - Abemaciclib in high risk early breast cancer
Presenter: Stephen Johnston
Session: Presidential Symposium II
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Solange Peters
Session: Presidential Symposium II
Resources:
Webcast
Invited Discussant LBA4 and 610O
Presenter: Henrik Grönberg
Session: Presidential Symposium II
Resources:
Slides
Webcast
Q&A live discussion
Presenter: Solange Peters
Session: Presidential Symposium II
Resources:
Webcast
Invited Discussant LBA5_PR
Presenter: George Sledge
Session: Presidential Symposium II
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Solange Peters
Session: Presidential Symposium II
Resources:
Webcast
Invited Discussant LBA3_PR
Presenter: Rafal Dziadziuszko
Session: Presidential Symposium II
Resources:
Slides
Webcast